LISANTI CAPITAL GROWTH, LLC Supernus Pharmaceuticals, Inc. Transaction History

LISANTI CAPITAL GROWTH, LLC portfolio value:

$12.97M
portfolio value

LISANTI CAPITAL GROWTH, LLC quarter portfolio value change:

+17.05%
quarter

Supernus Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -8.03% -33.47K shares 921K $33.85 383.18K
Q2 2022 share Increase +84.18% 190.43K shares 4.73M $28.92 416.65K
Q1 2022 share Decrease -25.70% -78.23K shares -1.56M $32.32 226.21K
Q4 2021 share Increase 0.00% 304.45K shares 8.87M $30.03 304.45K
Q3 2018 share Decrease -100.00% -60.67K shares -3.63M $50.35 0
Q2 2018 share Increase +46.39% 19.22K shares 1.73M $59.85 60.67K
Q1 2018 share Increase 0.00% 41.44K shares 1.89M $45.8 41.44K
Q4 2017 share Decrease -100.00% -25.92K shares -1.03M $39.85 0
Q3 2017 share Increase 0.00% 25.92K shares 1.03M $40 25.92K
Q2 2017 share Increase +322.24% 52.38K shares 2.44M $43.1 68.63K
Q1 2017 share Decrease -62.88% -27.53K shares -597K $31.3 16.25K
Q4 2016 share Increase +343.89% 33.92K shares 862K $25.25 43.79K
Q3 2016 share Decrease -73.46% -27.30K shares -513K $24.73 9.86K
Q2 2016 share Increase 0.00% 37.17K shares 757K $20.37 37.17K